PRA Group to Announce Fourth Quarter and Full Year 2017 Results on February 27
Feb 20, 2018 21:12 pm UTC| Business
NORFOLK, Va., Feb. 20, 2018 -- PRA Group, Inc. (Nasdaq:PRAA), a global leader in acquiring nonperforming loans, will report its fourth quarter and full year 2017 results after market close on Tuesday, February 27, 2018,...
Fentura Financial, Inc. Announces Quarterly Dividend
Feb 20, 2018 21:11 pm UTC| Business
FENTON, Mich., Feb. 20, 2018 -- The Board of Directors of Fentura Financial, Inc. (OTCQX:FETM) has announced a regular dividend of six cents per share for shareholders of record as of February 23, 2018, and payable...
Inovalon Reports Fourth Quarter and Full Year 2017 Results
Feb 20, 2018 21:10 pm UTC| Business
Fourth Quarter 2017 Highlights Fourth quarter revenue of $114.6 million, up 19% year-over-yearFourth quarter net income of $17.4 million, resulting in diluted net income of $0.12 per share, inclusive of a one-time...
Feb 20, 2018 21:10 pm UTC| Business
COLUMBUS, Ohio, Feb. 20, 2018 -- Worthington Industries, Inc. (NYSE:WOR) announced today that it has earned recognition as a Partner-level supplier for 2017 in the John Deere Achieving Excellence Program. This is the...
Feb 20, 2018 21:06 pm UTC| Business
RENO, Nev., Feb. 20, 2018 -- Monarch Casino Resort, Inc. (Nasdaq:MCRI) (“Monarch” or “the Company”) today reported operating results for the fourth quarter and full year ended December 31, 2017, as summarized below: ...
Avid Bioservices Announces Closing of Public Offering of Common Stock
Feb 20, 2018 21:06 pm UTC| Business
TUSTIN, Calif., Feb. 20, 2018 -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP) today announced the closing of its previously announced underwritten public offering of 10,294,445 shares of its common stock,...
Ultragenyx Reports Fourth Quarter and Full Year 2017 Financial Results and Corporate Update
Feb 20, 2018 21:06 pm UTC| Business
NOVATO, Calif., Feb. 20, 2018 -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today reported its financial...